XROMI Trademark

Trademark Overview

On Thursday, June 6, 2019, a trademark application was filed for XROMI with the United States Patent and Trademark Office. The USPTO has given the XROMI trademark a serial number of 79264145. The federal status of this trademark filing is REGISTERED as of Tuesday, May 26, 2020. This trademark is owned by Nova Bio-Pharma Technologies Ltd. The XROMI trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations, namely, oral solutions for treating sickle cell disease; oral solutions consisting of liquid medicine for treating sickle cell anaemia

Oral syringes for medical use
xromi

General Information

Serial Number79264145
Word MarkXROMI
Filing DateThursday, June 6, 2019
Status700 - REGISTERED
Status DateTuesday, May 26, 2020
Registration Number6061111
Registration DateTuesday, May 26, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, oral solutions for treating sickle cell disease; oral solutions consisting of liquid medicine for treating sickle cell anaemia
Goods and ServicesOral syringes for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 7, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, August 7, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNova Bio-Pharma Technologies Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLeicestershire LE184YL
GB
Party NameNova Bio-Pharma Technologies Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeicestershire LE18 4YL
GB
Party NameNova Bio-Pharma Technologies Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeicestershire LE18 4YL
GB

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 5, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 5, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, October 18, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 25, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 25, 2020FINAL DISPOSITION PROCESSED
Wednesday, August 26, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 26, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2020PUBLISHED FOR OPPOSITION
Saturday, March 7, 2020NOTIFICATION PROCESSED BY IB
Wednesday, February 19, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 19, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 5, 2019REFUSAL PROCESSED BY IB
Friday, September 13, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 13, 2019REFUSAL PROCESSED BY MPU
Wednesday, August 28, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 27, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 27, 2019ASSIGNED TO EXAMINER
Tuesday, August 13, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, August 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 1, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xromi oral treating sickle solutions cell medicine anaemia syringes medical liquid